Literature DB >> 19075417

Patient-reported barriers to glaucoma medication access, use, and adherence in southern India.

Betsy L Sleath1, R Krishnadas, Minhee Cho, Alan L Robin, Rakhi Mehta, David Covert, Gail Tudor.   

Abstract

The objectives of the study were to (a) describe the different types of problems that patients in southern India reported having when taking their glaucoma medications and (b) examine the relationship between patient reported-problems in taking their glaucoma medications and the self-reported patient adherence. A survey was conducted by clinical staff on 243 glaucoma patients who were on at least one glaucoma medication in an eye clinic in southern India. We found that 42% of patients reported one or more problems in using their glaucoma medications. Approximately 6% of patients reported being less than 100% adherent in the past week. Unmarried patients and patients who reported difficulty squeezing the bottle and difficulty opening the bottle were significantly more likely to report nonadherence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19075417      PMCID: PMC2661507          DOI: 10.4103/0301-4738.44495

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


It is estimated that by 2010 approximately 8.2 million people in India will have open-angle glaucoma and 3.7 million will have angle closure glaucoma, which translates to approximately 18.4% and 23.7% of the world's open-angle glaucoma and angle closure glaucoma, respectively.[1] In a study conducted in rural and urban populations in southern India, glaucoma was found to be responsible for 10.2% of bilateral blindness.[2] The absence of symptoms in almost all glaucoma patients increases the risk of treatment nonadherence among these patients. Prior work conducted in southern India examined why patients who felt the need for eye care did not utilize eye services.[34] To our knowledge, no prior study in India has examined self-reported problems of patients and adherence to glaucoma medications. Prior work in India has examined barriers and facilitators that affect adherence to antiretroviral medications and the patterns of prescribing and dispensing of medications by pediatric resident physicians.[5-7] Despite the availability of effective medications for glaucoma and greater awareness of the importance to follow these treatment regimens, patient nonadherence to prescribed therapy continues to be a significant problem.[89] The purpose of the current study was to (1) describe the different types of problems reported by the patients in India when taking their glaucoma medications and (2) examine the relationship between patient-reported problems in taking their glaucoma medications and patient adherence to treatment.

Materials and Methods

A survey to assess patient-reported problems and adherence to glaucoma medications that had been used in a prior U.S. study[9] was translated into Tamil; it included questions about the access to medication that were relevant to glaucoma patients living in India. The questions used to assess medication adherence were originally taken from the Brief Medication Questionnaire (BMQ).[10] The BMQ is a validated self-report measure of adherence.[10] Appendix A contains the questionnaire. The study was approved by the Aravind Institutional Review Board. Patients who received care at a large subspecialty glaucoma clinic in southern India participated in the survey. The survey questions were distributed by trained clinical staff to consecutive adult glaucoma patients taking glaucoma medications over a period of one month in 2006. The clinical staff assisted glaucoma patients who needed help. The survey was completed by 243 patients before they visited their ophthalmologists. All analyses were performed using SPSS (version 14.0). Descriptive statistics were calculated. Next, we examined the bivariate relationships between the independent and dependent variables using Fisher's exact tests and t -tests.

Results

Table 1 presents the demographic characteristics. Table 2 presents information about patient access to medications. Patients living in rural areas (28%) reported to take an hour or longer to get to their pharmacy than patients living in urban areas (11%; Fisher's exact test = 0.002).
Table 1

Patient demographic characteristics (N = 243)

Percent (N)
Sex
 Male64.2 (156)
 Female35.8 (87)
Lives in rural or urban area
 Urban59.3 (144)
 Rural40.7 (99)
Length of time with glaucoma
 Less than 1 year25.9 (63)
 1 to 2 years21.8 (53)
 More than 2 years51.8 (126)
Number of glaucoma medications
 181.5 (198)
 2 or 318.5 (45)
Number of times per day the patient takes glaucoma medications
 123.9 (58)
 268.3 (166)
 36.2 (15)
 40.8 (2)
 Missing0.8 (2)
Number of other non-glaucoma eye medications
 None83.5 (203)
 17.4 (18)
 24.1 (10)
 34.9 (12)
Education
 1 to 12 years71.2 (173)
 More than 12 years19.8 (48)
 Missing9.1 (22)
Marital status
 Married88.1 (214)
 Not married11.9 (29)
Patient states that a specific glaucoma medication bothers him/her
 Yes5.8 (14)
 No94.2 (229)
Glaucoma medications patient is supposed to be using but is not
 Patient is not using glaucoma medications that he/she should be using2.5 (6)
 Patient is using all glaucoma medications that he/she should be using 97.5 (237)
Patient administers drops himself
 Patient does not always administer himself11.1 (27)
 Patient always administers himself88.9 (216)
Less than 100% adherent in past week
 Yes5.8 (14)
 No94.2 (229)
Table 2

Access to medications (N = 243)

Percent (N)
How do you usually get your medication?
 I go to the pharmacy to pick up my medication.67.9 (185)
 Someone else picks up my medications at the pharmacy for me for free.26.7 (65)
 I pay someone to pick up my medications at the pharmacy for me.4.5 (11)
How far is the pharmacy from your home?
 Less than 5 kilometers61.3 (149)
 More than 5 kilometers, less than 10 kilometers8.6 (21)
 More than 10 kilometers29.6 (72)
How much time does it take to get to the pharmacy?
 Less than 30 minutes62.1 (151)
 Between 30 minutes and 1 hour19.8 (48)
 More than 1 hour to less than 2 hours8.6 (21)
 More than 2 hours9.1 (22)
How do you or your caregiver get to your pharmacy?
 Walk32.5 (79)
 Bike21.4 (52)
 Bus41.5 (101)
 Cart3.3 (8)
 Cab0.8 (2)
Patient demographic characteristics (N = 243) Access to medications (N = 243) Forty-two percent of patients reported one or more problems in using their glaucoma medications. Table 3 presents the types of patient-reported problems experienced by them. Younger patients were significantly more likely to report having difficulty paying for their medications (t -test = 2.00, P = 0.04) and getting their drops in their eyes (t -test = 2.27, P = 0.02) than older patients.
Table 3

Reported Problems /Difficulties in Taking Glaucoma Medications (N=243)

Percent (N)*
Drops fall on cheek8.6 (21)
Problem paying21.8 (53)
Too many drops come out9.9 (24)
Can't get drops in eyes9.9 (24)
Side effects3.3 (8)
Hard to squeeze the bottle4.5 (11)
Difficulty remembering10.7 (26)
Hard to open bottle2.5 (6)
Dosage times inconvenient7.0 (17)
Other2.1 (5)

The percentages do not total 100% because patients could report one or more problems.

Reported Problems /Difficulties in Taking Glaucoma Medications (N=243) The percentages do not total 100% because patients could report one or more problems. Approximately 6% of patients reported being less than 100% adherent to their glaucoma medications in the past week. Difficulty squeezing the bottle (Fisher's exact test, P = 0.04), difficulty opening the bottle (Fisher's exact test, P = 0.02), and not being married (Fisher's exact test, P = 0.016) were significantly related to whether the patient reported being less than 100% adherent to glaucoma treatment.

Discussion

Forty-two percent of patients reported one or more problems in using their glaucoma medications. Younger patients were significantly more likely to report difficulty paying for their medications and getting their drops in their eyes. This is an important finding and suggests that ophthalmologists and their clinical colleagues need to assess and make sure that patients, and especially the younger ones, know how to put their eye drops in. Also, providers need to assess whether patients, and especially those who are younger, can afford their medications, and if not, possibly prescribe something less expensive or help them receive their medications for free. Patients who reported difficulty opening their glaucoma eye drop bottle and squeezing the bottle were significantly more likely to report being less than 100% adherent. Providers should make sure to assess whether patients have difficulty opening their eye drop bottles and squeezing them. If the patients are having difficulty in these two areas, then providers could suggest that a family member or a friend help patients administer the eye drops. It is also interesting that unmarried patients were significantly more likely to report being less than 100% adherent. Providers should make sure to ask unmarried patients about what types of social support they have and whether they need assistance in managing their glaucoma. The providers could then help the patient find resources in their community to assist them in managing their glaucoma if this is needed. The study has several limitations. The clinical staff did not track those patients who refused to complete the survey. Second, the study enrolled only patients who were at the clinic for a glaucoma visit. Future research should examine the barriers to medication use among those in the community with glaucoma who have not returned for follow-up examinations. The generalizability of the study is limited because all patients were recruited at a single glaucoma clinic in southern India. Approximately 60% of the clinical patients stated that they lived in an urban area, which reflects the characteristics of individuals that receive care at this hospital. However, in other clinics in southern India, more patients might be from rural areas. The educational level reported by the patients reflects the educational level of patients living in this area of India. Despite the limitations, the study provides new information about the extent to which patients in India have problems getting and taking glaucoma medications and factors that contribute to patient adherence.

Conclusions

Forty-two percent of patients reported one or more problems in using their glaucoma medications. Approximately 6% of patients reported being less than 100% adherent to their glaucoma medications in the past week. Difficulty squeezing the bottle, difficulty opening the bottle, and not being married were significantly related to whether patients reported being less than 100 percent adherent.
Name of Glaucoma MedicationIn what way does it bother you?
a.
b.
c.
d.
NoneA littleA lot
a.My medication causes side effects012
b.It is hard to remember all the doses012
c.It is hard to pay for the medications012
d.The dosage times are inconvenient012
e.It is hard to open the bottle012
f.It is hard to get the drops in my eye012
g.Too many drops come out at the same time012
h.Drops fall on cheeks012
i.It is hard to squeeze the bottle012
j.My medication causes other problems or concerns012
If other problems or concerns explain:_____________________________________
Name of Glaucoma MedicationWhy are you not using it?
a.
b.
c.
d.
  10 in total

1.  Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India.

Authors:  A Wanchu; R Kaur; P Bambery; S Singh
Journal:  AIDS Behav       Date:  2007-01

2.  Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study.

Authors:  Sarah A Taylor; Sharon M Galbraith; Richard P Mills
Journal:  J Ocul Pharmacol Ther       Date:  2002-10       Impact factor: 2.671

3.  Patient-reported behavior and problems in using glaucoma medications.

Authors:  Betsy Sleath; Alan L Robin; David Covert; John E Byrd; Gail Tudor; Bonnie Svarstad
Journal:  Ophthalmology       Date:  2006-02-03       Impact factor: 12.079

4.  Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.

Authors:  N Kumarasamy; Steven A Safren; Sudha R Raminani; Robert Pickard; Romola James; A K Sri Krishnan; Suniti Solomon; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2005-08       Impact factor: 5.078

5.  The utilization of eye care services by persons with glaucoma in rural south India.

Authors:  Alan L Robin; Praveen K Nirmalan; Ramasamy Krishnadas; Rengappa Ramakrishnan; Joanne Katz; James Tielsch; Ravilla D Thulasiraj; David S Friedman
Journal:  Trans Am Ophthalmol Soc       Date:  2004

6.  Patterns of prescription and drug dispensing.

Authors:  Sunil Karande; Punam Sankhe; Madhuri Kulkarni
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

7.  Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey.

Authors:  R D Thulasiraj; Praveen K Nirmalan; R Ramakrishnan; R Krishnadas; T K Manimekalai; N P Baburajan; Joanne Katz; James M Tielsch; Alan L Robin
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

8.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

9.  Utilisation of eye care services in rural south India: the Aravind Comprehensive Eye Survey.

Authors:  P K Nirmalan; J Katz; A L Robin; R Krishnadas; R Ramakrishnan; R D Thulasiraj; J Tielsch
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

10.  The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence.

Authors:  B L Svarstad; B A Chewning; B L Sleath; C Claesson
Journal:  Patient Educ Couns       Date:  1999-06
  10 in total
  11 in total

1.  Glaucoma patient expression of medication problems and nonadherence.

Authors:  Catherine Slota; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Betsy Sleath
Journal:  Optom Vis Sci       Date:  2015-05       Impact factor: 1.973

2.  Quality of life in glaucoma patients after selective laser trabeculoplasty.

Authors:  Myrjam De Keyser; Maya De Belder; Veva De Groot
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

3.  Glaucoma treatment adherence at a United Kingdom general practice.

Authors:  A P Tse; M Shah; N Jamal; A Shaikh
Journal:  Eye (Lond)       Date:  2016-06-03       Impact factor: 3.775

4.  West Indies Glaucoma Laser Study (WIGLS): 1. 12-Month Efficacy of Selective Laser Trabeculoplasty in Afro-Caribbeans With Glaucoma.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  Am J Ophthalmol       Date:  2017-09-28       Impact factor: 5.258

5.  Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India.

Authors:  G N Subathra; Sharmila R Rajendrababu; Vijayalakshmi A Senthilkumar; Iswarya Mani; B Udayakumar
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

6.  An algorithm for glaucoma screening in clinical settings and its preliminary performance profile.

Authors:  S-Farzad Mohammadi; Sara Mirhadi; Hadi Z Mehrjardi; Akbar Fotouhi; Sahar Taba Taba Vakili; Mercede Majdi; Sasan Moghimi
Journal:  J Ophthalmic Vis Res       Date:  2013-10

7.  Adherence to topical glaucoma medications in Ethiopian patients.

Authors:  Lemlem Tamrat; Girum W Gessesse; Yeshigeta Gelaw
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

8.  Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India.

Authors:  Ketaki Rajurkar; Suneeta Dubey; Parmatma Prasad Gupta; Denny John; Lokesh Chauhan
Journal:  J Curr Ophthalmol       Date:  2018-06-08

9.  Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study.

Authors:  Joel Jun Kai Koh; Rui Xiang Cheng; Yicheng Yap; Victoria Haldane; Yao Guo Tan; Krichelle Wei Qi Teo; Aastha Srivastava; Pei Shi Ong; Pablo Perel; Helena Legido-Quigley
Journal:  Patient Prefer Adherence       Date:  2018-11-22       Impact factor: 2.711

10.  Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus.

Authors:  P Ranasinghe; R Jayawardena; P Katulanda; G R Constantine; V Ramanayake; P Galappatthy
Journal:  J Diabetes Res       Date:  2018-05-23       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.